 Cohorts of 3-6 patients receive escalating doses of melphalan until the maximum tolerated dose MTD is determined. The MTD is defined as the dose preceding that at which at least 2 of 3 or 2 of 6 patients experience dose-limiting toxicity. Once the MTD is determined, an additional 10 patients are treated at that dose. 